It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CYTK’s FA Score shows that 1 FA rating(s) are green whilePIRS’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CYTK’s TA Score shows that 2 TA indicator(s) are bullish while PIRS’s TA Score has 5 bullish TA indicator(s).
CYTK (@Biotechnology) experienced а -3.76% price change this week, while PIRS (@Biotechnology) price change was +4.98% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +0.72%. For the same industry, the average monthly price growth was +1.90%, and the average quarterly price growth was -0.55%.
CYTK is expected to report earnings on Oct 31, 2024.
PIRS is expected to report earnings on Aug 01, 2024.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
CYTK | PIRS | CYTK / PIRS | |
Capitalization | 6.33B | 22.4M | 28,250% |
EBITDA | -459.67M | -11.42M | 4,025% |
Gain YTD | -35.585 | 20.192 | -176% |
P/E Ratio | N/A | N/A | - |
Revenue | 3.13M | 20.9M | 15% |
Total Cash | 1.06B | 19.7M | 5,365% |
Total Debt | 790M | 0 | - |
CYTK | PIRS | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 59 | 52 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 100 Overvalued | 21 Undervalued | |
PROFIT vs RISK RATING 1..100 | 47 | 100 | |
SMR RATING 1..100 | 100 | 98 | |
PRICE GROWTH RATING 1..100 | 50 | 40 | |
P/E GROWTH RATING 1..100 | 1 | 100 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PIRS's Valuation (21) in the Biotechnology industry is significantly better than the same rating for CYTK (100). This means that PIRS’s stock grew significantly faster than CYTK’s over the last 12 months.
CYTK's Profit vs Risk Rating (47) in the Biotechnology industry is somewhat better than the same rating for PIRS (100). This means that CYTK’s stock grew somewhat faster than PIRS’s over the last 12 months.
PIRS's SMR Rating (98) in the Biotechnology industry is in the same range as CYTK (100). This means that PIRS’s stock grew similarly to CYTK’s over the last 12 months.
PIRS's Price Growth Rating (40) in the Biotechnology industry is in the same range as CYTK (50). This means that PIRS’s stock grew similarly to CYTK’s over the last 12 months.
CYTK's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for PIRS (100). This means that CYTK’s stock grew significantly faster than PIRS’s over the last 12 months.
CYTK | PIRS | |
---|---|---|
RSI ODDS (%) | N/A | 1 day ago90% |
Stochastic ODDS (%) | 1 day ago82% | 1 day ago81% |
Momentum ODDS (%) | 1 day ago79% | 1 day ago85% |
MACD ODDS (%) | 1 day ago71% | N/A |
TrendWeek ODDS (%) | 1 day ago77% | 1 day ago84% |
TrendMonth ODDS (%) | 1 day ago74% | 1 day ago83% |
Advances ODDS (%) | 6 days ago83% | 1 day ago83% |
Declines ODDS (%) | 1 day ago75% | 5 days ago87% |
BollingerBands ODDS (%) | 1 day ago76% | 1 day ago90% |
Aroon ODDS (%) | N/A | 1 day ago74% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PEMX | 55.37 | 0.07 | +0.13% |
Putnam Emerging Markets Ex-China ETF | |||
UTEN | 45.61 | -0.05 | -0.11% |
US Treasury 10 Year Note ETF | |||
CRPT | 11.48 | -0.06 | -0.52% |
First Trust SkyBdg Cry Idt & Dgt Eco ETF | |||
IYM | 145.48 | -1.02 | -0.70% |
iShares US Basic Materials ETF | |||
SPGP | 103.83 | -0.98 | -0.94% |
Invesco S&P 500 GARP ETF |
A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with TVTX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then TVTX could also see price increases.
Ticker / NAME | Correlation To CYTK | 1D Price Change % | ||
---|---|---|---|---|
CYTK | 100% | -3.27% | ||
TVTX - CYTK | 57% Loosely correlated | +1.06% | ||
VBIVQ - CYTK | 44% Loosely correlated | +6.56% | ||
KRON - CYTK | 43% Loosely correlated | +6.59% | ||
IOVA - CYTK | 42% Loosely correlated | -1.93% | ||
DARE - CYTK | 42% Loosely correlated | -2.65% | ||
More |
A.I.dvisor indicates that over the last year, PIRS has been closely correlated with BPTSY. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if PIRS jumps, then BPTSY could also see price increases.
Ticker / NAME | Correlation To PIRS | 1D Price Change % | ||
---|---|---|---|---|
PIRS | 100% | +3.00% | ||
BPTSY - PIRS | 89% Closely correlated | -6.88% | ||
FUSN - PIRS | 67% Closely correlated | N/A | ||
FATE - PIRS | 51% Loosely correlated | -3.25% | ||
MDGL - PIRS | 39% Loosely correlated | -3.64% | ||
CYTK - PIRS | 38% Loosely correlated | -3.27% | ||
More |